Stockscreener 앱 받기
4.38
1.35%
-0.06
시간 외 거래:
4.50
0.12
+2.74%
전일 마감가:
$4.44
열려 있는:
$4.47
하루 거래량:
258.47K
Relative Volume:
1.38
시가총액:
$67.78M
수익:
-
순이익/손실:
$-5.98M
주가수익비율:
-12.16
EPS:
-0.3603
순현금흐름:
$-9.83M
1주 성능:
+7.88%
1개월 성능:
+12.31%
6개월 성능:
+41.29%
1년 성능:
+71.76%
1일 변동 폭
$4.2601
$4.5124
1주일 범위
$4.04
$4.7143
52주 변동 폭
$1.75
$4.7143
Grace Therapeutics Inc Stock (GRCE) Company Profile
명칭
Grace Therapeutics Inc
전화
609-322-1602
주소
103 CARNEGIE CENTER, PRINCETON
Compare GRCE vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
4.38 | 68.70M | 0 | -5.98M | -9.83M | -0.3603 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-02 | 개시 | TD Cowen | Buy |
| 2020-09-01 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-07-06 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2020-01-13 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2019-08-29 | 개시 | B. Riley FBR | Buy |
| 2019-07-18 | 개시 | Oppenheimer | Outperform |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
모두보기
Grace Therapeutics Inc 주식(GRCE)의 최신 뉴스
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences - The Manila Times
MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease - The Manila Times
Why some brain bleed patients miss full doses takes center stage at 2 meetings - Stock Titan
Market Trends: Is KIMPRN a play on infrastructure spending2026 WrapUp & Fast Entry High Yield Tips - baoquankhu1.vn
Traumatic Brain Injury Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Neuren Pharma, NeuroVive Pharma, Stemedica Cell Techn, Grace Lab - Barchart
Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Update - MarketBeat
Is Grace Therapeutics Inc. stock positioned for digital transformation2025 Trade Ideas & AI Forecasted Entry and Exit Points - Naître et grandir
Aug Selloffs: What is the cash position of Willis Lease Finance Corporation2025 Short Interest & Technical Confirmation Alerts - baoquankhu1.vn
Aug Patterns: Will Haoxin Holdings Limited stock outperform Nasdaq indexTrend Reversal & Weekly Watchlist for Hot Stocks - Naître et grandir
Moderna | History, Innovation, Challenges, & Facts | Britannica Money - Britannica
Aug Momentum: Is now the right time to enter SAIA2025 AllTime Highs & Low Risk High Win Rate Picks - baoquankhu1.vn
GRCE SEC FilingsGrace Therapeutics, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
GRCE: IV nimodipine shows superior efficacy and compliance over oral forms for aSAH treatment - TradingView
Institution Moves: What is Grace Therapeutics Incs valuation compared to sector2025 Trade Ideas & Safe Entry Zone Tips - baoquankhu1.vn
Is OXLC.G forming a breakout patternPortfolio Performance Report & Free Daily Entry Point Trade Alerts - mfd.ru
Rate Hike: Can Grace Therapeutics Inc weather a recessionProfit Target & Reliable Price Action Trade Plans - baoquankhu1.vn
ANTX PE Ratio & Valuation, Is ANTX Overvalued - Intellectia AI
PYPD PE Ratio & Valuation, Is PYPD Overvalued - Intellectia AI
GRCE Should I Buy - Intellectia AI
Buy Signal: Is MSAI forming a breakout pattern2025 Trading Volume Trends & Expert Approved Momentum Ideas - baoquankhu1.vn
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - Bitget
Grace CEO joins TD Cowen event with IV nimodipine program - Stock Titan
The 9 Best Robinhood Penny Stocks in March 2026 - The Stock Dork
Stop Loss: Does CRVS stock benefit from AI growthWeekly Trade Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
NVIDIA Corporation (NVDA) to Supply Standalone Grace CPUs in Landmark Data Center Rollout - Yahoo Finance
Companies Like Grace Therapeutics (NASDAQ:GRCE) Are In A Position To Invest In Growth - Sahm
ADAR1 discloses 9.9% Grace Therapeutics (GRCE) ownership in 13G/A - Stock Titan
Aug PreEarnings: Is Grace Therapeutics Inc a turnaround storyMarket Risk Report & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
SAPMY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Can MetaVia Inc. stock outperform in a bear marketTreasury Yields & Proven Capital Preservation Methods - mfd.ru
Will Grace Therapeutics Inc. stock sustain high P E ratios2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
Does Grace Therapeutics Inc. have a sustainable dividend2025 Volume Leaders & Real-Time Volume Surge Alerts - mfd.ru
Is EVGOW stock a top momentum playPortfolio Update Report & Daily Entry Point Alerts - mfd.ru
Is SFYX stock good for wealth creation2025 Price Momentum & Real-Time Volume Analysis - mfd.ru
GRCE PE Ratio & Valuation, Is GRCE Overvalued - Intellectia AI
BOL.ST Should I Buy - Intellectia AI
Analysts Are Bullish on Top Healthcare Stocks: Grace Therapeutics (GRCE), Alto Neuroscience, Inc. (ANRO) - The Globe and Mail
Is Grace Therapeutics Inc. still a buy after recent gainsWeekly Trading Summary & Technical Pattern Alert System - mfd.ru
Amy C. Moore and Roland Matthews: When Professional Excellence Meets Personal Grace - Oncodaily
Grace Therapeutics announces third quarter 2026 financial results, provides business update - marketscreener.com
Grace Therapeutics (NASDAQ:GRCE) Announces Earnings Results - MarketBeat
Grace Therapeutics (GRCE) Advances Towards FDA Review with Promi - GuruFocus
Is Grace Therapeutics Inc. a cyclical or defensive stockWeekly Stock Summary & Accurate Trade Setup Notifications - mfd.ru
Grace: Fiscal Third Quarter Earnings Overview - Bitget
Grace: Fiscal Q3 Earnings Snapshot - kare11.com
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update - The Manila Times
Grace Therapeutics Q3 2026 Financial Results and Business Update - TradingView
April 23 FDA target date set for Grace’s GTx-104 aSAH drug - Stock Titan
Grace Therapeutics, Inc. SEC 10-Q Report - TradingView
Why is Grace Therapeutics Inc. stock going upShort Setup & Verified Trade Idea Suggestions - mfd.ru
Grace Therapeutics reports Q3 loss - National Today
Grace Therapeutics Inc (GRCE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):